568 related articles for article (PubMed ID: 31003094)
1. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
[TBL] [Abstract][Full Text] [Related]
2. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071
[TBL] [Abstract][Full Text] [Related]
3. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
4. The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Mika J
J Neuroimmune Pharmacol; 2017 Sep; 12(3):402-419. PubMed ID: 28337574
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
6. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses.
Kwiatkowski K; Ciapała K; Rojewska E; Makuch W; Mika J
Int Immunopharmacol; 2020 Jul; 84():106540. PubMed ID: 32402949
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain.
Imai S; Ikegami D; Yamashita A; Shimizu T; Narita M; Niikura K; Furuya M; Kobayashi Y; Miyashita K; Okutsu D; Kato A; Nakamura A; Araki A; Omi K; Nakamura M; James Okano H; Okano H; Ando T; Takeshima H; Ushijima T; Kuzumaki N; Suzuki T; Narita M
Brain; 2013 Mar; 136(Pt 3):828-43. PubMed ID: 23364351
[TBL] [Abstract][Full Text] [Related]
9. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.
Zajaczkowska R; Kwiatkowski K; Pawlik K; Piotrowska A; Rojewska E; Makuch W; Wordliczek J; Mika J
Pharmacol Rep; 2020 Oct; 72(5):1310-1322. PubMed ID: 32691345
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
Front Immunol; 2019; 10():2198. PubMed ID: 31616413
[TBL] [Abstract][Full Text] [Related]
11. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CCL7 mediates trigeminal neuropathic pain
Zhu LP; Xu ML; Yuan BT; Ma LJ; Gao YJ
Mol Pain; 2023; 19():17448069231169373. PubMed ID: 36998150
[TBL] [Abstract][Full Text] [Related]
13. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Pawlik K; Piotrowska A; Kwiatkowski K; Ciapała K; Popiolek-Barczyk K; Makuch W; Mika J
Immunology; 2020 Apr; 159(4):413-428. PubMed ID: 31919846
[TBL] [Abstract][Full Text] [Related]
14. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia.
Pevida M; Lastra A; Hidalgo A; Baamonde A; Menéndez L
Brain Res Bull; 2013 Jun; 95():21-7. PubMed ID: 23562605
[TBL] [Abstract][Full Text] [Related]
15. Chemokine CCL7 regulates spinal phosphorylation of GluA1-containing AMPA receptor via interleukin-18 in remifentanil-induced hyperalgesia in rats.
Qiang Z; Yu W
Neurosci Lett; 2019 Oct; 711():134440. PubMed ID: 31430547
[TBL] [Abstract][Full Text] [Related]
16. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
[TBL] [Abstract][Full Text] [Related]
17. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.
Van Steenwinckel J; Reaux-Le Goazigo A; Pommier B; Mauborgne A; Dansereau MA; Kitabgi P; Sarret P; Pohl M; Mélik Parsadaniantz S
J Neurosci; 2011 Apr; 31(15):5865-75. PubMed ID: 21490228
[TBL] [Abstract][Full Text] [Related]
18. SETD7 mediates spinal microgliosis and neuropathic pain in a rat model of peripheral nerve injury.
Shen Y; Ding Z; Ma S; Ding Z; Zhang Y; Zou Y; Xu F; Yang X; Schäfer MKE; Guo Q; Huang C
Brain Behav Immun; 2019 Nov; 82():382-395. PubMed ID: 31505256
[TBL] [Abstract][Full Text] [Related]
19. Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Hamed EA; Mohamed Farghaly HS; Abdel Mola AF; Fahmi MK; Makhlouf MM; Balfas MA
J Basic Clin Physiol Pharmacol; 2016 Jun; 27(4):411-24. PubMed ID: 26974138
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
